News and Updates
eMediNexus Coverage from: 
FDA Approves Asthma Drug Benralizumab for At-Home Use
eMediNexus,  08 October 2019
remove_red_eye 497 Views
#Allergy and Immunology #Pathology and Lab Medicine #Pharmacist #Pulmonary Medicine

1 Read Comments                

The US Food and Drug Administration has approved a self-administered version of benralizumab (Fasenra, AstraZeneca), which comes in a prefilled, single-use autoinjector (Fasenra Pen), the company has announced.Benralizumab is an antieosinophil humanized monoclonal antibody that selectively targets the interleukin-5 receptor expressed on the surface of eosinophils… (Medscape)
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now